Third Rock Ventures
Third Rock Ventures is a venture capital firm dedicated to building innovative companies that transform the lives of patients. Founded in 2007, the firm focuses on translating scientific discoveries into breakthrough medicines, with a mission to create sustainable companies that address unmet medical needs. Third Rock Ventures emphasizes collaboration among experts in science, medicine, business, and strategy to push the boundaries of science and technology.
Third Rock Ventures
201 Brookline Ave, Suite 1401, Boston, MA 02215
What We Do
Third Rock Ventures provides a comprehensive company creation strategy that includes discovering emerging fields of science, launching companies with necessary resources, building experienced management teams, and transforming companies to bring products to patients.
Industry Focus
Portfolio
Trace Neuroscience is focused on expanding genomic medicine for neurodegenerative diseases.
#Biopharmaceutical
Candid Therapeutics develops transformative drugs for autoimmune diseases.
#Biotechnology
Marea Therapeutics is developing medicines for cardiometabolic diseases.
#Biotechnology
Clasp Therapeutics specializes in precision immuno-oncology using T cell engagers.
#Biotechnology
Develops small molecule therapies for validated disease targets.
#Precision Medicine